The intended use forms the basis for classification as a medical product. It is imperative that the classification is in place early on, as an elevated medical classification may place additional requirements for the underlying development processes, product requirements and documentation. The classification is made on the basis of the “intended use” and the communication with which the product is promoted.
It is essential that the intended use and communication are consistent. As an example, the difference between the statements “The chair supports the lower back” and “The chair supports people with problems in the lower back” will determine whether or not one is dealing with a medical product.
When describing the intended use as a manufacturer, one should clarify how one specifically aims to prove that the product actually works according to its intended use. Therefore, it should be ensured, as far as possible, that the intended use is formulated in a measurable form, since the effect of the product must be shown in the form of a clinical evaluation - e.g. in user trials before marketing.
The clinical evaluation includes literature studies on the effect of similar products as well as analysis and assessment of which safety factors have played a role in other similar products. It may be unlawful to market non-state-of-the-art medical products whose deficiencies when compared to competing solutions pose an increased risk to the user.
On the flip side, there is obviously very little advantage in studying competing solutions or the safety-related conditions of competing solutions, as one’s own design is largely complete, and incentives for improvement are therefore typically very limited. Some companies choose to enter the market with the anticipation of an update in the near future. They often don’t realise that an update may very well require renewed approvals and updating of large amounts of documentation. It is highly recommended to adhere to the standards for User-friendliness (IEC 60601-1-6 / 62366-1) and EN ISO 14155-1 regarding clinical study, partly to ensure compliance with the standards, but more importantly to plan and streamline the development process and ensure that all relevant data is collected as early as possible for the safety and quality of the product.


